By Tian Jingxin
As the FBI and SWAT teams uncovered yet another illegal laboratory filled with deadly pathogens in a garage in Las Vegas, a disturbing pattern is emerging. This case is no longer simply about the illegal handling of medical waste—it involves false identities, China’s military-civil fusion system, and a deliberately chosen location near U.S. military strategic sites, forming part of a broader biological threat network.
Key figure: 62-year-old Chinese citizen Jia Bei Zhu
As the investigation progresses, U.S. intelligence and lawmakers increasingly believe that these “unregulated” labs scattered across the United States could be probes or forward outposts for an “asymmetric war” Beijing might be waging against the U.S.
Chameleon: from Chinese executive to North American fugitive
According to records from the U.S. House of Representatives’ Special Committee on U.S.-China Strategic Competition and Canadian court documents, Jia Bei Zhu once held an executive position in China’s environmental science and engineering sector, with his early companies deeply involved in government-funded projects.
Success
You are now signed up for our newsletter
Success
Check your email to complete sign up
Before entering the U.S., Zhu ran a company in Vancouver. In 2016, he was sued for allegedly stealing millions of dollars in intellectual property from U.S. companies and was ordered to pay CAD 330 million. Ignoring the court order, he fled Canada and entered the U.S. under a forged identity.
In the U.S., Zhu assumed the name “David He” and presented himself as a biotechnology consultant. Investigations show he operated bio-labs through shell companies such as Universal Meditech Inc. (UMI) and Prestige Biotech Inc. (PBI) without any regulatory oversight. These companies had no permits to handle high-risk pathogens yet were able to import and transport biological materials with ease.
Strategic location: ‘under the US military’s nose’
The Las Vegas case, when compared with a prior case in Reedley, California, reveals a chilling commonality: the labs’ locations are highly strategically sensitive. This consistency appears far from coincidental.
The Reedley lab was in California’s Central Valley, only about 30 miles from NAS Lemoore, one of the U.S. Navy’s largest fighter bases and home to Pacific Fleet F-35C Lightning II and F/A-18 Super Hornet aircraft. The lab stored COVID-19, malaria, HIV, and thousands of gallons of biofuels and chemical reagents—any accidental release or weaponization could pose a direct biosafety threat to military personnel and their families.
The newly discovered Las Vegas lab on the east side of the city is even more strategically sensitive. It is extremely close to Nellis Air Force Base (Nellis AFB), a key U.S. Air Force combat training center, the site of the Red Flag exercises, and a core area for testing new tactics and studying foreign military materials.
Intelligence analysts note that placing genetically modified pathogen labs near core U.S. military bases fits a “gray zone” tactic, serving both as intelligence-gathering outposts and potential deployment points for biological agents in a conflict scenario.
Terrifying inventory: from ‘COVID mice’ to agro-terrorism
Investigators are linking the Las Vegas discovery with the earlier Reedley case. The Reedley lab, operated by Prestige Biotech and UMI, was essentially an unregulated “Pandora’s box” of biological hazards.
Court documents list thousands of test tubes containing COVID-19, HIV, hepatitis, malaria, tuberculosis, and shockingly, Ebola virus. Over 900 lab mice were bred, some genetically engineered. Experts warn this indicates potential use for agricultural terrorism, targeting U.S. crops or livestock.
Environmental risks are equally urgent. In both Reedley and Las Vegas, improperly stored chemicals and unlabelled waste could easily contaminate groundwater or air. Smuggled fungi or genetically modified organisms could devastate a critical strategic sector: agriculture.
Funding links to China’s military-civil fusion
The House Special Committee’s investigation revealed a complex funding network behind Zhu’s companies. As probes extended internationally, the case grew more opaque. Financial tracing shows Zhu’s funds originated directly from Chinese banks, sparking questions about state-level involvement.
Congressional reports explicitly linked Zhu to the Chinese Communist Party’s “Military-Civil Fusion” strategy, under which private businesses’ commercial activities are often used to support military objectives. Intelligence analysts note Zhu was not a first-time offender; his history in Canada involved systematic IP theft, raising suspicions about potential corporate espionage or deeper intelligence activities.
Despite appearing bankrupt and disorganized, Zhu’s companies still obtained large sums to purchase centrifuges and lab equipment. Investigators found funds transferred from China through multiple layers of transactions, resembling money laundering.
Zhu’s operations were not limited to counterfeiting; they also involved stealing U.S. biotech. In the Reedley warehouse, investigators found viruses and large quantities of imitation U.S. medical devices, a strategic effort to weaken U.S. biotech and transfer it back to China. This highlights major blind spots in U.S. biosecurity regulation. How could these labs operate unnoticed for so long?
Defense and ownership questions
Zhu’s lawyer, Anthony Capozzi, denied Zhu’s direct involvement in the Las Vegas lab, citing his current federal detention as preventing him from controlling external activities. However, property records tie the Las Vegas residence directly to Zhu and his associated entities, suggesting the criminal network continued operating through proxies even after the primary suspect was detained.
April trial and key charges
Zhu Bei Jia and his associate Zhaoyan Wang are set for trial in April 2026 in the Eastern District of California. Federal prosecutors have brought serious charges:
- Illegal Manufacturing and Sales: Producing and selling mislabelled medical devices without FDA approval (including COVID and pregnancy tests).
- False Statements: Providing false information to regulators about product sources and nature.
- Fraud Conspiracy: Colluding to defraud by selling substandard medical products for huge profits.
Prosecutors emphasized that Universal Meditech’s FDA registration had expired, and it lacked emergency use authorization (EUA) during the pandemic, confirming its illegal operations.
Regulatory and national security gaps
The Las Vegas discovery exposes major gaps in U.S. biosecurity oversight. Current regulation relies heavily on chance reporting, leaving a passive system vulnerable. Lawmakers are calling for stricter scrutiny of biotech imports, foreign investments, and laboratory equipment flows.
From a national security perspective, Zhu’s Chinese funding and alleged military links raise the question: is this state-supported “asymmetric warfare” or purely opportunistic crime?
The Reedley lab was discovered only after a local officer noticed a garden hose; similarly, the Las Vegas lab was raided only after a tip. Residential bio-labs remain almost entirely unregulated in the U.S. How did deadly pathogens enter the country through customs and move interstate without detection?
Invisible threats
With Zhu facing new charges and the FBI digging deeper into the Las Vegas lab, the American public faces a stark reality: biological threats are no longer confined to distant P4 labs—they could be lurking in a garage in an ordinary neighborhood, just miles from U.S. military air bases.
From a public safety perspective, the case sends clear warnings:
- Corporate Responsibility: Medical and agriculture-related companies must rigorously vet supply chains to ensure reagents, equipment, and technologies are legitimate and compliant.
- Public Vigilance: Citizens can push for stricter regulations and report unusual odors, chemical deliveries, or non-residential equipment in neighborhoods.
- National Resilience: Bio-defense depends not only on federal agencies but also on local communities’ awareness.
The core significance of cases like this is in promoting transparency and early warning mechanisms. Only by addressing these details can policymakers develop effective strategies, ensuring such discoveries serve as historical warnings rather than recurring threats.
